1. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.
    Nan Feng et al, 2016, Mol Med Rep CrossRef
  2. Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma
    DONGXU ZHAO et al, 2014 CrossRef
  3. Identification of 7-(4′-Cyanophenyl)indoline-1-benzenesulfonamide as a mitotic inhibitor to induce apoptotic cell death and inhibit autophagy in human colorectal cancer cells
    Tung-Yun Wu et al, 2017, Sci Rep CrossRef
  4. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation
    Zheng Dong et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  5. XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells.
    You-Jin Lee et al, 2017, Environ Toxicol CrossRef
  6. Crosstalk between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
    Abdelouahid El-Khattouti et al, 2013, Journal of Cell Death CrossRef
  7. Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma
    Hideyuki Takata et al, 2016 CrossRef
  8. Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
    Zili Wang et al, 2017 CrossRef
  9. Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells.
    Li Wang et al, 2013, Int J Mol Sci CrossRef
  10. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy
    Ying-Ying Li et al, 2017, IJMS CrossRef
  11. Low-level laser irradiation at a high power intensity increased human endothelial cell exosome secretion via Wnt signaling
    Hesam Saghaei Bagheri et al, 2018, Lasers Med Sci CrossRef
  12. Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
    Grant R. Campbell et al, 2018, J. Biol. Chem. CrossRef
  13. NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
    Cheng-Ming Hsu et al, 2018, Cell Death Discovery CrossRef
  14. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
    Jialin Ren et al, 2018, Diagn Pathol CrossRef
  15. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
    Cheng-Ming Hsu et al, 2018, IJMS CrossRef
  16. Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
    Hamza Yazdani et al, 2019, Cells CrossRef
  17. Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply
    Ken Liu et al, 2017, Clinical and Translational Gastroenterology CrossRef
  18. Emerging strategies to effectively target autophagy in cancer
    V W Rebecca et al, 2016, Oncogene CrossRef
  19. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.
    L Chang et al, 2014, Cell Death Dis CrossRef
  20. null
    Jennifer W. Harris et al, 2015 CrossRef
  21. Inhibiting Autophagy
    Michael T. Lotze et al, 2013, The Cancer Journal CrossRef
  22. Molecular therapy of colorectal cancer: Progress and future directions
    Wenhao Weng et al, 2014, Int. J. Cancer CrossRef
  23. Untangling knots between autophagic targets and candidate drugs, in cancer therapy
    Tao Xie et al, 2015, Cell Prolif. CrossRef
  24. null
    Alfredo Fort et al, 2015 CrossRef
  25. Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma
    Ying Chen et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
  26. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
    Cally J. Ho et al, 2019, Cancers CrossRef
  27. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
    Tuhina Khan et al, 2019, Med Res Rev CrossRef
  28. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men
    Silvia Ribback et al, 2015, Oncotarget CrossRef
  29. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
    Cheng-Chan Yu et al, 2020, Molecules CrossRef
  30. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line
    Jing Han et al, 2019, Mol Med Report CrossRef
  31. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in�maxillary primordium mesenchymal cells
    Tao Han et al, 2019, Int J Mol Med CrossRef
  32. COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
    Zheying Zhang et al, 2018, Int J Oncol CrossRef
  33. The anticancer activities of Vernonia amygdalina Delile. Leaves on 4T1 breast cancer cells through phosphoinositide 3-kinase (PI3K) pathway
    Poppy Anjelisa Zaitun Hasibuan et al, 2020, Heliyon CrossRef
  34. Endoplasmic reticulum stress and protein degradation in chronic liver disease
    Si-Wei Xia et al, 2020, Pharmacological Research CrossRef
  35. Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
    Qin Xia et al, 2020, Front. Oncol. CrossRef
  36. Targeting autophagy to overcome drug resistance: further developments.
    Haocai Chang et al, 2020, J Hematol Oncol CrossRef
  37. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy
    Elisabetta Ninfole et al, 2021, WJCC CrossRef
  38. Hepatocellular carcinoma (HCC): The most promising therapeutic targets in the preclinical arena based on tumor biology characteristics
    Haichuan Wang et al, 2021, Expert Opinion on Therapeutic Targets CrossRef
  39. Salvianolic acid B improves autophagic dysfunction and decreases the apoptosis of cholesterol crystal‑induced macrophages via inhibiting the Akt/mTOR signaling pathway.
    Mengqi Sun et al, 2021, Mol Med Rep CrossRef
  40. The crosstalk between sonodynamic therapy and autophagy in cancer
    Yujie Zhang et al, 2022, Front. Pharmacol. CrossRef
  41. Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-κB and Akt/mTOR pathway activation
    Tao Zou et al, 2022, Sci Rep CrossRef
  42. Diindolylmethane Inhibits Cadmium-Induced Autophagic Cell Death via Regulation of Oxidative Stress in HEL299 Human Lung Fibroblasts
    Yeon-Seop Jung et al, 2022, Molecules CrossRef
  43. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
    Mahshid Deldar Abad Paskeh et al, 2023, Pharmacol Res CrossRef
  44. Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
    Azar Gharoonpour et al, 2023, Front. Oncol. CrossRef
  45. A review on the potential risks and mechanisms of heavy metal exposure to Chronic Obstructive Pulmonary Disease
    Shuxia Yu et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  46. Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells
    Mi-Young Kim et al, 2019, Molecules and Cells CrossRef
  47. 4″-Alkyl EGCG Derivatives Induce Cytoprotective Autophagy Response by Inhibiting EGFR in Glioblastoma Cells
    Satyam Singh et al, 2024, ACS Omega CrossRef
  48. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells
    Minsoo Koh et al, 2024, Autophagy CrossRef
  49. Simultaneous activation and blockade of autophagy to fight hepatocellular carcinoma
    Hala Shalhoub et al, 2024, Autophagy Reports CrossRef
  50. Construction of an Immunogenic Cell Death-Related Gene Signature and Genetic Subtypes for Predicting Prognosis, Immune Microenvironments, and Drug Sensitivity in Hepatocellular Carcinoma
    Shuo Li et al, 2024, JIR CrossRef
  51. null
    Sameer Ullah Khan et al, 2024 CrossRef